This Rakesh Jhunjhunwala-owned pharma stock hits over 4-year high

Lupin rose 4 per cent to Rs 1,258.70 on the BSE in intra-day trade on Wednesday, a level that was last seen in May 2017

Shares of Lupin hit an over four-year high of Rs 1,258.70, up 4 per cent on the BSE in intra-day trade on Wednesday on the back of heavy volumes in an otherwise weak market on expectations of healthy growth in the near term. The stock of the pharmaceutical company was trading at its highest level since May 2017.

Till 11:14 am, trading volumes on the counter nearly doubled with a combined 3.54 million shares having changed hands on the NSE and BSE so far. In comparison, the S&P BSE Sensex was down 0.56 per cent at 51,641 points.

Ace investor